Stock Market Analysis Zynerba: Repeated Trial Failures, Some Post Hoc Success by Avisol Capital Partners Contributor since 2017 / 16772 Followers 3 years ago Summary: ZYNE has a cannabidiol gel it is running through various trials. The company and